3rd Tumor Myeloid-Directed Therapies Summit

3rd Tumor Myeloid-Directed Therapies Summit

 July 18 to July 20, 2023 

Hilton Boston Logan Airport, One Hotel Drive, Boston, Massachusetts, 02128, United States

The role of the myeloid compartment in tumor resistance is becoming clear. As the landscape of targets continues to grow, the potential to target and manipulate myeloid cells to relieve immunosuppression has received increasing focus, due to its ability to relieve immunosuppression in the tumor microenvironment.

The 3rd Tumor Myeloid-Directed Therapies Summit captures this potential by uniting the industry leaders pioneering these myeloid activating therapies to share clinical progress while reviewing novel targets to activate macrophages, monocytes, dendritic cells and more.

Collaborate and learn from myeloid experts across industry and academia over 3 in-depth days of content, as they address the key bottlenecks limiting the efficacy and safety of these exciting treatments, including in vivo models, biomarkers of response, combination rationale, and myeloid biology to accelerate myeloid directed therapies

Read on tumor-myeloid-therapeutics.com

Continue reading at

Related Offerings

Interested in this event?

Next Event

  • July

    39th Annual Geriatric Care Conference

     July 18, 2023 

    The Kahler Grand Hotel, 20 2nd Avenue Southwest, Rochester, Minnesota, 55902, United States

    39th Annual Geriatric Care Conference

Medigy Innovation Network

Connecting innovation decision makers to authoritative information, institutions, people and insights.

Medigy Logo

The latest News, Insights & Events

Medigy accurately delivers healthcare and technology information, news and insight from around the world.

The best products, services & solutions

Medigy surfaces the world's best crowdsourced health tech offerings with social interactions and peer reviews.

© 2024 Netspective Media LLC. All Rights Reserved.

Built on Jun 21, 2024 at 7:13am